GN Store Nord: Divesting Hearing
The sale of Hearing changes the case. GN is no longer a misunderstood MedTech compounder with a temporary cyclical problem. It is becoming an exposed peripherals company. This is the Fjord Alpha take.
When GN Store Nord announced the sale of its Hearing division to Amplifon, the market liked it, and it traded up 30+% intraday. That reaction is easy to understand. The company gets a large cash injection, net debt is effectively removed, and the structure becomes much simpler. On the surface, this looks attractive. Investors usually like simplification, and they usually like balance sheet repair even more.
